Here are five notes:
1. The firm gave AmSurg a $90 price target.
2. Cantor Fitzgerald has a “buy” rating on AmSurg shares.
3. The price target indicates a 43.75 percent potential upside for AmSurg shares.
4. The market cap. is $3.37 billion.
5. AmSurg’s P/E ratio is 18.58.
More articles on surgery centers:
Carle submits CON application to relocate surgery center — 5 takeaways
How physicians and hospitals can benefit from joint ventures
Independent vs. hospital-associated ASCs: Mutually assured destruction or an uneasy truce?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
